And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Topic: Psoriasis

What Skincare Products are Best for Psoriasis? thumbnail
Play Button

What Skincare Products are Best for Psoriasis?

Series: Ask Dr. Friedman | July 1, 2020

Not many topical formulations tout benefits for psoriasis, but that doesn't mean there are no useful products. Dr. Friedman offers his take.

Watch Video
DermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns thumbnail
Play Button

DermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns

Series: DermWire TV | April 16, 2020

SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.”  Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients ages 6 to under 18. LEO Pharma’s Finacea Foam (azelaic acid 15%) is back in pharmacies—just in time for Rosacea Awareness Month.

Watch Video
Psoriasis Update: Understanding the Latest Psoriasis Guidelines thumbnail
Play Button

Psoriasis Update: Understanding the Latest Psoriasis Guidelines

Series: Dermatology Dispatches | April 10, 2020

In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of psoriasis.

Watch Video
IL-23 Inhibitors: Update on Safety and Dosing thumbnail
Play Button

IL-23 Inhibitors: Update on Safety and Dosing

Series: Dermatology Dispatches | April 9, 2020

With more experience using IL-23 inhibitors to treat psoriasis, dermatologists are seeing high levels of patient satisfaction and no new safety signals. Jennifer Cather, MD assesses the clinical experience.

Watch Video
COVID-19 Impact: Decisions, decisions: Treating Psoriasis thumbnail
Play Button

COVID-19 Impact: Decisions, decisions: Treating Psoriasis

Series: Dermatology Dispatches | April 9, 2020

Physicians need to carefully weigh the risks and benefits of treating psoriasis patients with biologics or immunosuppressant agents during the COVID-19 pandemic, says Jashin J. Wu, MD. Many factors affect this decision including the severity of the psoriasis as well as any underlying medical conditions that increase risk for a severe course of COVID-19 including diabetes, hypertension, or liver disease.

Watch Video

Advertisement

The Latest in Psoriasis

Advertisement

View more